Literature DB >> 8097419

Diabetes mellitus in cystic fibrosis: genetic and immunological markers.

S Lanng1, B Thorsteinsson, F Pociot, M O Marshall, H O Madsen, M Schwartz, J Nerup, C Koch.   

Abstract

Family history, as well as genetic and immunological markers of diabetes mellitus, were studied in cystic fibrosis (CF) patients with and without diabetes mellitus. Positive family history of diabetes mellitus in first-degree relatives was found in only 6 of 210 (3%) CF patients, with no difference between non-diabetic and diabetic patients. The frequency distributions of the HLA types DR3, DR4 and DR3/4, which normally confer susceptibility to insulin-dependent diabetes mellitus and of HLA-DR2, which normally confers resistance to insulin-dependent diabetes mellitus, were not different in non-diabetic CF patients, diabetic CF patients and normal subjects. The genotypic frequencies of tumor necrosis factor-beta and of heat shock protein 70, located within the HLA region on chromosome 6, in CF patients with diabetes were not different from those in patients with insulin-dependent diabetes mellitus, while non-diabetic CF patients and normal subjects shared other patterns. The frequencies of the interleukin-1 beta alleles, located on chromosome 2, were not different in non-diabetic and diabetic CF patients, insulin-dependent diabetic patients and normal subjects. Islet cell cytoplasmic antibodies, measured before, at and after the diagnosis of diabetes in 33 diabetic CF patients and in 32 matched non-diabetic CF patients, were detected in only 2 of 236 (0.8%) serum samples: in a pre-diabetic patient and in a non-diabetic control patient. Birth weights were not different in diabetic and non-diabetic CF patients, arguing against the importance of the intrauterine environment as a determinant in the transmission of diabetes mellitus in CF patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097419     DOI: 10.1111/j.1651-2227.1993.tb12628.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  13 in total

1.  Islet Hormone and Incretin Secretion in Cystic Fibrosis after Four Months of Ivacaftor Therapy.

Authors:  Andrea Kelly; Diva D De Leon; Saba Sheikh; Devaney Camburn; Christina Kubrak; Amy J Peleckis; Darko Stefanovski; Denis Hadjiliadis; Michael R Rickels; Ronald C Rubenstein
Journal:  Am J Respir Crit Care Med       Date:  2019-02-01       Impact factor: 21.405

2.  Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure.

Authors:  Rebecca L Hull; Ronald L Gibson; Sharon McNamara; Gail H Deutsch; Corinne L Fligner; Charles W Frevert; Bonnie W Ramsey; Srinath Sanda
Journal:  Diabetes Care       Date:  2018-02-01       Impact factor: 19.112

Review 3.  Survival in a bad neighborhood: pancreatic islets in cystic fibrosis.

Authors:  Andrew W Norris; Katie Larson Ode; Lina Merjaneh; Srinath Sanda; Yaling Yi; Xingshen Sun; John F Engelhardt; Rebecca L Hull
Journal:  J Endocrinol       Date:  2019-02-01       Impact factor: 4.286

4.  Glucose tolerance in patients with cystic fibrosis: five year prospective study.

Authors:  S Lanng; A Hansen; B Thorsteinsson; J Nerup; C Koch
Journal:  BMJ       Date:  1995-09-09

Review 5.  Update on gene modifiers in cystic fibrosis.

Authors:  Joseph M Collaco; Garry R Cutting
Journal:  Curr Opin Pulm Med       Date:  2008-11       Impact factor: 3.155

Review 6.  The Clinical Biology of Cystic Fibrosis Transmembrane Regulator Protein: Its Role and Function in Extrapulmonary Disease.

Authors:  Theodore G Liou
Journal:  Chest       Date:  2018-10-22       Impact factor: 9.410

Review 7.  Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review.

Authors:  Antoinette Moran; Dorothy Becker; Samuel J Casella; Peter A Gottlieb; M Sue Kirkman; Bruce C Marshall; Bonnie Slovis
Journal:  Diabetes Care       Date:  2010-12       Impact factor: 19.112

8.  A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis.

Authors:  S M Blackman; S Hsu; S E Ritter; K M Naughton; F A Wright; M L Drumm; M R Knowles; G R Cutting
Journal:  Diabetologia       Date:  2009-07-08       Impact factor: 10.122

Review 9.  Heterogeneity in the severity of cystic fibrosis and the role of CFTR gene mutations.

Authors:  M Dean; G Santis
Journal:  Hum Genet       Date:  1994-04       Impact factor: 4.132

10.  Cystic fibrosis-related diabetes is associated with HLA DQB1 alleles encoding Asp-57- molecules.

Authors:  M Carrington; L J Krueger; D S Holsclaw; M C Iannuzzi; M Dean; D Mann
Journal:  J Clin Immunol       Date:  1994-11       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.